Here’s how Qantas Frequent Flyer makes money for the company
How Qantas Frequent Flyer makes money is a key question any investors looking at or invested in Qantas should ask.…
Trump appears to have made Meme Coins Great Again: But you still should not invest in them!
After a couple of years out of the spotlight, Meme coins are back in focus once more. There had been…
Tesla’s Future Under Trump: Will Energy Policies Boost or Challenge Its Growth?
The future of Tesla, a national electric vehicle sector player, will surely change under government policy initiatives. During the Trump…
What’s Next for NVIDIA? How Will Trump’s Stargate Project Impact Its Growth?
NVIDIA is the foremost power in AI hardware and software solutions, and thus the Stargate project, initially spearheaded by Donald…
The Evolution of MA Financial Group: What It Means for Investors in Australia
MA Financial Group, initially established as Moelis Australia in 2009, has grown significantly into a prominent financial services organisation. The…
Are $TRUMP and $MELANIA Coins Just a Trend, or the Next Game-Changer in Crypto?
With several controversies and trends circulating, speculation has been buzzing in the crypto world. From meme coins like Dogecoin to…
Crypto Under Trump 2.0: Will His Policies Fuel or Hinder Digital Currency Growth?
With the prospect of Trump coming back into the White House right on the horizon, the interest in his stance…
Top ASX Retail Stocks for 2025: Here Are Our 5 Picks!
Here Are Our 5 Top ASX Retail Stocks for 2025! Baby Bunting (ASX:BBN) Baby Bunting has bottomed out from…
Trump’s National Emergency Declaration: What Does It Mean for Oil and Gas Stocks?
On 20 January 2025, President Donald Trump declared a national energy emergency, marking a significant shift in U.S. energy policy.…
Analysts aren’t optimistic about iron ore prices in 2025, will they be right and what will it mean for iron ore stocks?
In which direction will iron ore prices in 2025 go? Chinese trade data would suggest upwards, and indeed prices jumped…
Paradigm Biopharmaceuticals’ flagship drug Zilosul will be in Phase 3 in 2025
Paradigm Biopharmaceuticals (ASX:PAR) has been listed for nearly a decade with the goal of bringing its flagship drug pentosan polysulfate…
Findi (ASX:FND): It’s quadrupled in 12 months off the back of financial services in India
Until Findi (ASX:FND) came along, there were practically no ASX companies making money from India (or at least not many…
Here are 5 key ASX Listing Rules that investors need to know about!
All companies listed on the ASX need to know about the ASX Listing Rules. The reason is obvious: Because there’s…
Here are 3 ASX stocks fighting diabetes and the opportunity ahead of them
There aren’t many ASX stocks fighting diabetes, but the few that are have a big market opportunity ahead of them. And…
Predictive Discovery (ASX:PDI): It’s got a 4.2Moz gold deposit, but should you buy now?
Few stocks have ever gained more than 700% in a day, but Predictive Discovery (ASX:PDI) did just that back in…